← Leaderboards
Rie Sakai-Bizmark
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center
$1,565,129
Attributed
$1,565,129
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $368.7K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,565,129 · 3
By mechanism
R21$877,116 · 2
K01$688,013 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Family”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$49,374,001
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,270,371
- Lynn Briscoe · Leidos Biomedical Research, Inc.$23,229,499
- Badri N Vardarajan · University Of Miami School Of Medicine$20,570,414
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
Research focus
FamilyHospitalsNeonatal ScreeningInnovationLifeMortalityEligibility DeterminationCharacteristicsFutureInfant OutcomeCostCongenital Heart DisorderLive BirthMorbidity - Disease RateAdherenceDiagnosisAreaCathetersAffectFaceInterviewInfantBaseNewborn Infant
Grant awards (9)
Suicidal Behavior among Adolescents Experiencing Homelessness in the US during the COVID-19 Pandemic$193,568
R21 · FY2025 · MH · contact PI
Suicidal Behavior among Adolescents Experiencing Homelessness in the US during the COVID-19 Pandemic$259,773
R21 · FY2024 · MH · contact PI
Disparities in the effect of state policy for the newborn screening for critical congenital heart diseases$192,625
R21 · FY2022 · HD · contact PI
Newborn Screening for Critical Congenital Heart Disease in U.S.: Assessment of implementation obstacles and application of cost-effectiveness to gauge if action needed for improved implementation$137,619
K01 · FY2022 · HL · contact PI
Disparities in the effect of state policy for the newborn screening for critical congenital heart diseases$231,150
R21 · FY2021 · HD · contact PI
Newborn Screening for Critical Congenital Heart Disease in U.S.: Assessment of implementation obstacles and application of cost-effectiveness to gauge if action needed for improved implementation$137,537
K01 · FY2021 · HL · contact PI
Newborn Screening for Critical Congenital Heart Disease in U.S.: Assessment of implementation obstacles and application of cost-effectiveness to gauge if action needed for improved implementation$137,619
K01 · FY2020 · HL · contact PI
Newborn Screening for Critical Congenital Heart Disease in U.S.: Assessment of implementation obstacles and application of cost-effectiveness to gauge if action needed for improved implementation$137,619
K01 · FY2019 · HL · contact PI
Newborn Screening for Critical Congenital Heart Disease in U.S.: Assessment of implementation obstacles and application of cost-effectiveness to gauge if action needed for improved implementation$137,619
K01 · FY2018 · HL · contact PI